Literature DB >> 670401

The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver.

A Balsam, S H Ingbar.   

Abstract

As judged from both paper and column chromatography, slices or homogenates of liver from rats fasted for 48 h displayed a lesser rate of generation of (125)I-labeled 3,5,3'-triiodothyronine (T(3)) from (125)I-labeled thyroxine (T(4)) added to incubation media than did preparations from normal chow-fed animals. A similar defect in the conversion of T(4) to T(3) in the livers of fasted animals was observed when preparations were incubated with substrate concentrations of T(4) so that T(3) generation could be assessed by radioimmunoassay. The effect of fasting could be prevented, wholly or in part, by administration of glucose in the drinking water to otherwise fasted animals, and the degree of prevention appeared to be proportional to the concentration of glucose employed. Diminished generation of T(3) from T(4) was similarly evident in the livers of animals with streptozotocin-induced diabetes mellitus, and this defect was overcome by the provision of insulin in vivo, but not in vitro. Decreased formation of T(3) from T(4) was also observed in preparations of liver from animals given dexamethasone, amiodarone, and propylthiouracil. In no case could these effects on the net formation of T(3) from T(4) be explained by effects of the experimental conditions on the degradation of the T(3) generated, as judged from the rate of degradation of exogenous (125)I-T(3) measured in parallel incubates. An analysis of the rate of disappearance of (125)I-T(4) from reaction mixtures in relation to the rate of appearance of (125)I-T(3) and (125)I-iodide was employed to estimate the activity of the 5-monodeiodinating pathway of T(4) metabolism that leads to the formation of 3,3',5'-triiodothyronine (reverse T(3)). Such estimates indicated that reverse T(3) formation was actively proceeding in the preparations studied, was slightly enhanced by fasting, was unaffected by dexamethasone and amiodarone, and was markedly inhibited by propylthiouracil. In view of the similarities between the effect of these experimental manipulations on the generation of T(3) from T(4) by rat liver in vitro to their effects on the production rates and serum concentrations of T(3) in man, it is concluded that the rat liver system provides a suitable model for the study of factors that influence the conversion of T(4) to T(3) in man. In addition, the findings strongly indicate that this process, at least in the liver, is closely linked to the utilization of carbohydrate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670401      PMCID: PMC371780          DOI: 10.1172/JCI109143

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

Review 1.  Active form of the thyroid hormone.

Authors:  S H Ingbar; L E Braverman
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

2.  Effect of caloric restriction and dietary composition of serum T3 and reverse T3 in man.

Authors:  S W Spaulding; I J Chopra; R S Sherwin; S S Lyall
Journal:  J Clin Endocrinol Metab       Date:  1976-01       Impact factor: 5.958

3.  Dexamethasone suppression of serum T3 and T4.

Authors:  L J Degroot; K Hoye
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

4.  An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man.

Authors:  I J Chopra
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

5.  Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting.

Authors:  A G Vagenakis; A Burger; G I Portnary; M Rudolph; J R O'Brian; F Azizi; R A Arky; P Nicod; S H Ingbar; L E Braverman
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

6.  Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.

Authors:  S Nomura; C S Pittman; J B Chambers; M W Buck; T Shimizu
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

7.  Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).

Authors:  I J Chopra; D E Williams; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

8.  Circulating thyroid hormones and thyrotropin in adult patients with protein-calorie malnutrition.

Authors:  I J Chopra; S R Smith
Journal:  J Clin Endocrinol Metab       Date:  1975-02       Impact factor: 5.958

9.  Low serum triiodothyronine in patients with anorexia nervosa.

Authors:  T Moshang; J S Parks; L Baker; V Vaidya; R D Utiger; A M Bongiovanni; P J Snyder
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

10.  High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease.

Authors:  F Bermudez; M I Surks; J H Oppenheimer
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

View more
  31 in total

1.  Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment.

Authors:  Matthew L Rosene; Gábor Wittmann; Rafael Arrojo e Drigo; Praful S Singru; Ronald M Lechan; Antonio C Bianco
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

2.  Glucose-evoked recovery of hepatic thyroxine 5'-deiodinase independent of de novo protein synthesis in fasted rat.

Authors:  M Nishida; C S Pittman
Journal:  Experientia       Date:  1990-01-15

3.  Influence of type II 5' deiodinase on TSH content in diabetic rats.

Authors:  C Aláez; R Calvo; M J Obregón; C Alvarez; L Goya; F Escrivá; M A Martín; A M Pascual-Leone
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

4.  Thyroid hormones homeostasis in rats refed after short-term and prolonged fasting.

Authors:  Z Kmiec; G Kotlarz; B Smiechowska; A Mysliwski
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

Review 5.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

6.  Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting.

Authors:  A Balsam; S H Ingbar
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

7.  Thyroid hormone balance in beluga whales, Delphinapterus leucas: dynamics after capture and influence of thyrotropin.

Authors:  D J St Aubin; J R Geraci
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

8.  Variations of thyroid hormones during total fasting in obese and in obese diabetic subjects.

Authors:  M Marugo; M Bagnasco; M Contessini; D Bessarione; F Schenone; D Mignone; D Bernasconi; G Mazzocchi; M Giusti
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

9.  Glucose and free fatty acid turnover in normal subjects and in diabetic patients before and after insulin treatment.

Authors:  S E Hall; J Saunders; P H Sönksen
Journal:  Diabetologia       Date:  1979-05       Impact factor: 10.122

10.  Effect of dietary carbohydrates during hypocaloric treatment of obesity on peripheral thyroid hormone metabolism.

Authors:  R Pasquali; M Parenti; L Mattioli; M Capelli; G Cavazzini; G Baraldi; G Sorrenti; G De Benedettis; P Biso; N Melchionda
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.